At the University of Hull, we recently celebrated the opening of Allam Medical Building the heart of the University of Hull’s £28 million health campus and our home in Hull. The investment being made in the health campus is increasing our capacity to deliver life-changing research, enabling us to attract academic expertise and funding.
The opening of the £2.4 million Wolfson Centre for Palliative Care Research is enabling us to build on ongoing research in palliative care, to further help those with life limiting illnesses. An investment of over £5 million from Yorkshire Cancer Research is helping us to build on our cancer research – impacting the way cancer is understood, diagnosed and treated at a regional and national level. We will soon be celebrating the launch of a new Institute for Clinical and Applied Health Research, which will bring health professionals together to collaborate on a range of research methods and fields including trials, epidemiology and health economics.
The University of York has an international reputation for academic excellence, it is also one of the most successful research universities in the UK and was placed in the top ten UK universities by the 2008 Research Assessment Exercise. This commitment to excellence in research and to further strengthening research to be dynamic, inspirational and life changing in its impact means our staff benefit from a stimulating and supportive environment in which to challenge thinking, innovate and impact.
Our researchers have a global reputation for their work. From scientific discoveries that underpin the development, diagnosis and treatment of diseases, to mental health research which addresses the needs of a wider variety of patients and helps to identify treat and support them, this work is casting new light and impacting global public health. Recent discoveries include new information about how to boost our immune system’s fight against cancer, research into the link between mental and physical health which is improving outcomes and services for patients with diabetes and mental illness, and global trials to help develop a vaccine against the parasitic disease leishmaniasis.